gms | German Medical Science

information platform

Germany, Land of Ideas

Deutsche Initiative für Netzwerkinformation (DINI, German Initiative for Network Information)

Your initial contact to the requested addressee


Here you can get in touch with the recipient specified below.

All indicated mandatory fields () have to be completed.
Using this functionality for commercial advertising is prohibited.

Recipient: Max E. Scheulen
Article: Phase II Study of First Line Sorafenib (BAY 43-9006) in Patients with Locally Advanced and/or Metastatic Pancreatic Cancer – a Study of the Central European Society for Anticancer Drug Research - EWIV (CESAR)
27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO127 (PO127)